Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Gong

Showing results (771-780 of 813) with videos related to

Pageof 82
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
Factors Associated With Detection and Survival of T1 Hepatocellular Carcinoma in the United States: National Cancer Database AnalysisJu Dong Yang, Michael Luu, Amit G Singal, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 31, 2012
[Morphologic diagnosis and onset characteristics of acute leukemia: a retrospective analysis of 233 cases in 10 years]Yi Liu, You-Zhang Huang, Li-Zhong Gong, et al.
Annals of Surgical Oncology|April 8, 2018
Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular CarcinomaXiao-Lu Ma, Mi Jiang, Ying Zhao, et al.
Cancer Immunology, Immunotherapy : CII|March 2, 2024
Molecular classification reveals the sensitivity of lung adenocarcinoma to radiotherapy and immunotherapy: multi-omics clustering based on similarity network fusionJianguo Zhang, Yangyi Li, Weijing Dai, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 26, 2020
Elevated soluble programmed death-ligand 1 levels indicate immunosuppression and poor prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolizationXiao-Lu Ma, Xu-Dong Qu, Wen-Jing Yang, et al.
Physiological Genomics|February 27, 2023
Screening of candidate genes related to differences in growth and development between Chinese indigenous and Western pig breedsXuan Tao, Fan-Jing Kong, Yan Liang, et al.
Nature Medicine|December 12, 2017
The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitisPeng Zhang, Pi-Xiao Wang, Ling-Ping Zhao, et al.
Molecular Cancer|August 27, 2020
Upregulation of METTL14 mediates the elevation of PERP mRNA N<sup>6</sup> adenosine methylation promoting the growth and metastasis of pancreatic cancerMin Wang, Jun Liu, Yan Zhao, et al.
The American Journal of Gastroenterology|February 12, 2026
Antibiotic Use Linked to Worse Outcomes in Gastrointestinal and Liver Cancer Patients on Immune Checkpoint Inhibitors: A Meta-AnalysisMohammad Saeid Rezaee-Zavareh, Hamidreza Karimi-Sari, Peyvand Parhizkar Roudsari, et al.
Nature Medicine|May 9, 2017
Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4Guang-Nian Zhao, Peng Zhang, Jun Gong, et al.
Pageof 82

Showing results (771-780 of 813) with videos related to

Sort By:
Pageof 82
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
Factors Associated With Detection and Survival of T1 Hepatocellular Carcinoma in the United States: National Cancer Database AnalysisJu Dong Yang, Michael Luu, Amit G Singal, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 31, 2012
[Morphologic diagnosis and onset characteristics of acute leukemia: a retrospective analysis of 233 cases in 10 years]Yi Liu, You-Zhang Huang, Li-Zhong Gong, et al.
Annals of Surgical Oncology|April 8, 2018
Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular CarcinomaXiao-Lu Ma, Mi Jiang, Ying Zhao, et al.
Cancer Immunology, Immunotherapy : CII|March 2, 2024
Molecular classification reveals the sensitivity of lung adenocarcinoma to radiotherapy and immunotherapy: multi-omics clustering based on similarity network fusionJianguo Zhang, Yangyi Li, Weijing Dai, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 26, 2020
Elevated soluble programmed death-ligand 1 levels indicate immunosuppression and poor prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolizationXiao-Lu Ma, Xu-Dong Qu, Wen-Jing Yang, et al.
Physiological Genomics|February 27, 2023
Screening of candidate genes related to differences in growth and development between Chinese indigenous and Western pig breedsXuan Tao, Fan-Jing Kong, Yan Liang, et al.
Nature Medicine|December 12, 2017
The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitisPeng Zhang, Pi-Xiao Wang, Ling-Ping Zhao, et al.
Molecular Cancer|August 27, 2020
Upregulation of METTL14 mediates the elevation of PERP mRNA N<sup>6</sup> adenosine methylation promoting the growth and metastasis of pancreatic cancerMin Wang, Jun Liu, Yan Zhao, et al.
The American Journal of Gastroenterology|February 12, 2026
Antibiotic Use Linked to Worse Outcomes in Gastrointestinal and Liver Cancer Patients on Immune Checkpoint Inhibitors: A Meta-AnalysisMohammad Saeid Rezaee-Zavareh, Hamidreza Karimi-Sari, Peyvand Parhizkar Roudsari, et al.
Nature Medicine|May 9, 2017
Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4Guang-Nian Zhao, Peng Zhang, Jun Gong, et al.
Pageof 82